Document:

<PAGE>
                                                                   Exhibit 10.53

(BIOGEN LOGO)                                    Vice President, Human Resources

FOURTEEN CAMBRIDGE CENTER, CAMBRIDGE, MA 02142 - 617-679-2000 - FAX 617-679-3595

                                 October 8, 2001

Craig Eric Schneier, Ph.D.
175 Highland Terrace
Princeton, NJ 08540

Dear Craig:

On behalf of Jim Mullen, I am pleased to offer you the opportunity to join
Biogen as an employee and member of the senior leadership team. Pursuant to our
recent discussions, and in consideration of my decision to retire from active
employment with Biogen on or about December 31, 2002, you are offered the
position of Senior Vice President, Strategic Organization Design and
Effectiveness, reporting to me. Your base salary rate will be $10,576.92 payable
biweekly ($275,000 annualized) and beginning in 2002, you will participate in
Biogen's Annual Incentive Compensation Plan with a target of 40% of your base
salary. You will continue in your role as Senior Vice President, Strategic
Organization Design and Effectiveness, until no later than December 31, 2002,
upon which you will be appointed Executive Vice President, Human Resources,
reporting to Jim Mullen, President and Chief Executive Officer of Biogen. At
that time, your base salary rate will be increased to $11,538.46 payable
biweekly ($300,000 annualized) and your annual Incentive Compensation Plan
target will be increased to 50% of your base salary. Your principal place of
employment will be at Biogen's headquarters in the Cambridge Massachusetts area.

Upon employment, you will receive $500,000 as a one-time special cash payment,
split into two components:

     -    $250,000 as an interest-free forgivable loan (the "Forgivable Loan")
          which forgives over a thirty-six month, straight-line schedule;

     -    $250,000 as an interest-free mortgage loan (the "Mortgage Loan")
          repayable to Biogen the sooner of eighteen months following the point
          in time the after-tax profit of your vested stock options exceeds
          $1,000,000 or five (5) years from your date of employment.

In the event that you voluntarily terminate your employment, or Biogen
terminates your employment for poor performance or cause, prior to the
thirty-six months from the date of the Forgivable Loan, the unforgiven portion
of the Forgivable Loan would be payable to Biogen within six months of your
termination date.

If you voluntarily terminate your employment, or if your employment is
terminated by Biogen for poor performance or cause, prior to the repayment of
the Mortgage Loan, you will be required to repay Biogen the entire amount of the
Mortgage Loan the sooner of six months following the termination of your
employment or the closing on the sale of the property by which the loan is then
secured.

Effective on the date you commence employment, you will be granted an option to
purchase 100,000 shares of the common stock of Biogen Inc. which is subject to
the approval of the Stock and Option Plan

<PAGE>

(BIOGEN LOGO)

Dr. Craig Eric Schneier
October 8, 2001
Page 2

Administration Committee of the Board of Directors, which we expect to be
forthcoming. The exercise price per share will be the average of the high and
low sale prices as reported in the National Association of Securities Dealers
Automated Quotation System ("NASDAQ") on the date you commence employment. The
option will have a ten-year term and vest over a four-year period at the rate of
25% per year starting on the anniversary of the date you commence employment. In
the future, based on your performance, you will be eligible for merit stock
option grants beginning at year-end 2002 pursuant to Biogen's merit stock option
policy and in-line with awards granted to the Executive Vice Presidents.

The Board of Directors recently approved an amendment to our stock option plan
which provides the acceleration of stock option vesting based on the change in
control of the corporation and a corresponding adverse impact to the individual
officer which otherwise causes the individual to lose the unvested stock option
grants made by Biogen.

As an officer of the Company, you will be required to participate in our program
for executive stock ownership, which we are currently revising and expect to
have approved by December. We believe it is very important that our key leaders
have personal stock ownership.

You will be able to choose from a menu of benefit options through our flexible
benefits program, BioChoice. These include health care, dependent life, and
disability insurance as well as two flexible spending accounts, Med-Flex and
D-Flex, for eligible medical or dependent care expenses. At the beginning of the
calendar quarter following your date of employment you will be eligible to
participate in Biogen's pension plan. Biogen also offers a variety of additional
benefits including 401(k) savings plans, childcare and elder care referral
service, educational matching gifts, credit union, and group homeowners and
automobile insurance. You will receive more detailed information regarding your
benefits on your first day of employment.

Biogen will provide relocation benefits to facilitate your move from Princeton,
NJ. A relocation counselor will contact you to discuss the relocation program,
and will send you a package detailing the relocation policy to you. Please read
the policy carefully as it will outline the parameters of these benefits and
detail the reimbursement process. These benefits will include the reimbursement
of many of the costs associated with both the sale of your current house and the
purchase of a new house in the Boston area; home finding; and movement of your
household goods. Since you will need temporary living in the Boston area until
such time as your family will be joining you in mid-2002, Biogen will provide an
apartment for your use in the Cambridge/Boston vicinity.

Additionally, in your new role and subsequently, as Executive Vice President,
Human Resources you will be provided the following:

-    Vacation: You are entitled, during your employment with Biogen, to four (4)
     weeks vacation, accrued on a monthly pro-rated basis.

-    Supplemental Savings Plan: You are entitled, during your employment with
     Biogen, to participate in the Voluntary Executive Supplemental Savings
     Plan. This plan allows you to defer from your current

<PAGE>

(BIOGEN LOGO)
Dr. Craig Eric Schneier
October 8, 2001
Page 3

     taxation up to 50% of your base salary and 100% of your bonus, if there is
     one. I can outline the details of the program if you are interested in
     participating.

-    Life Insurance: You will be provided, during your employment with Biogen,
     Biogen's Executive Term Life Insurance coverage which equals three times
     your base salary (annualized).

-    Tax Review/Preparation: You are entitled, during your employment with
     Biogen, to the preparation and/or review, including review of the estimated
     taxes of your annual Federal and State tax returns, which is currently
     administered through PricewaterhouseCoopers. The cost of this service is
     covered by Biogen. In the event that you choose to continue the services
     provided by your current tax advisor, Biogen will reimburse you the cost of
     these services up to but not exceeding the amount incurred by Biogen
     through PricewaterhouseCoopers.

-    Severance Benefits: If your employment with Biogen is terminated by Biogen
     without cause for reasons including a change in control of the corporation
     or separately, if Jim Mullen is no longer the President and Chief Executive
     Officer of Biogen and your employment with Biogen terminates, you will be
     entitled to receive severance benefits calculated as a minimum of nine
     months and accruing beyond the minimum benefit level at the rate of three
     months per year of service to a maximum benefit of eighteen months payable
     as a lump-sum cash payment. The lump-sum cash payment, before tax
     withholding, shall equal your final monthly annual compensation times the
     number of months for which you are eligible. Annual monthly compensation
     would equal your base salary plus target bonus modified by individual
     performance. Biogen will continue to provide employer-sponsored health
     insurance benefits during the severance period until you would begin
     receiving health insurance coverage from another employer or the end of the
     severance benefit period, whichever occurs first, You will not be an
     employee of Biogen during the severance period and you will not accrue any
     benefits or other rights (such as, but not limited to, pension plan vesting
     or accrual, stock option vesting, vacation pay, etc.) during such period
     except health benefits as described above. In addition to the severance
     benefits described above, the unforgiven amount of the Forgivable Loan
     referenced on the first page of this letter would be forgiven based on the
     definition of termination as noted herein.

Commencement of employment with Biogen is contingent on the satisfactory
completion of a pre-employment drug-screening test at least five business days
prior to your start date. We require all new employees to sign an Intellectual
Property/Confidentiality Agreement on the first day of employment.

It is Biogen's policy to comply with federal, state and local guidelines
applicable to its facilities and to take all reasonable steps to ensure the
health and safety of Biogen employees. Consistent with this policy, your normal
duties may require you from time to time to attend meetings or perform functions
in any or all of Biogen's facilities.

The Federal Government requires you to provide proper identification verifying
your eligibility to work in the United States. Please bring the appropriate
identification with you on your first day of employment.

On behalf of Jim Mullen, we very much look forward to your positive response. As
I believe you know, we are confident that you will make a significant
contribution to Biogen's future success.

<PAGE>

(BIOGEN LOGO)
Dr. Craig Eric Schneier
Octobers 8, 2001
Page 4

Please confirm your acceptance by signing this offer letter. I also invite you
to complete the enclosed invitation to self identify. Please complete the
employment application and the drug screen authorization forms and then return
all signed documents to me in the enclosed self addressed, stamped envelope. The
other original offer letter is for your records.

                                        Sincerely

                                        /s/ Frank A. Burke, Jr.
                                        ----------------------------------------
                                        Frank A. Burke, Jr.

FAB:bk
Enclosures

cc: Mr. James C. Mullen

I am pleased to accept the offer of employment described above.

ACCEPTED:

/s/ Craig Eric Schneier
-------------------------------------
Craig Eric Schneier, Ph.D.

For timely processing of your medical and dental benefit enrollment forms please
fill in the appropriate information:

Birth Date: October 13, 1947 Social Security Number ________________(BIOGEN LOGO)

INTEROFFICE MEMORANDUM

DATE:    August 28, 2002

TO:      Craig Eric Schneier, Ph.D.

cc:      James C. Mullen
         Peter N. Kellogg
         Personnel File

FROM:    Frank A. Burke, Jr.

SUBJECT: Reimbursement for Mortgage Interest

This memorandum will serve to evidence the agreement of Biogen to pay to you an
amount sufficient to reimburse you for the additional interest expense you will
incur as a result of the inability of Biogen to fund a mortgage loan to you.

When you accepted employment with Biogen, the company committed to lending you
$250,000 for up to five years without interest - to assist you in the
acquisition of a new residence in Massachusetts. The loan was to be secured by a
mortgage on the new residence. A copy of the proposed promissory note is
attached to this memorandum as Exhibit A. Subsequent to when Biogen committed to
making the loan, but prior to funding it, a federal law was enacted barring a
publicly traded company from lending funds to its executive officers. Biogen is
a publicly traded company and you are an executive officer of Biogen; therefore,
Biogen cannot lend you funds as previously committed to you.

To afford you the economic value of the now proscribed loan, Biogen and you have
agreed to pay to you an amount equivalent to the additional interest expense you
will incur financing the acquisition of your new residence in Massachusetts in
the absence of the loan from Biogen. Based on the difference between terms of
the proposed promissory note and your actual financing, your mortgage lender,
Chase Mortgage, has calculated that you will pay $1,323.00 in additional
interest each month (see worksheet attached to this memorandum as Exhibit B).
Biogen will pay to you this amount each month beginning August 15, 2002.
Reimbursement of the additional interest expense by Biogen will cease at such
time as you would have been obligated to repay in full the loan in accordance
with the terms of the proposed promissory note.

Biogen's reimbursement of the additional interest expense will constitute income
paid to you and will be subject to federal and state income and welfare taxes.
You will be responsible for the payment of all such taxes. If you refinance the
bank loan used to acquire your new residence in Massachusetts and, therefore,
your actual interest expense per month is reduced, Biogen's payments to you will
be equitably reduced.

/bk
Attachments

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}]]